HAEMONETICS CORP - 8-K Filing
Haemonetics enters non-exclusive supply agreement with CSL Plasma to provide NexSys PCS devices in the U.S., expecting rollout completion by end of 2027 (Items: 7.01 Regulation FD DisclosureOn August 18, 2026, Haemonetics Corporation (the “Company”) furnished a Current Report on Form 8-K disclosing its ent)
Tickers: $HAE